The purpose of this study is to analyze the efficacy of MicroRNAs as biomarkers on the Chagas Disease prognosis. This analysis will be done through the correlation between the plasmatic levels of this molecule with functional and laboratory tests.
The patients included in the study must at first sign the written consent. They shall be accompanied in the specialized outpatient clinics for Chagas disease - Hospital São Rafael - Centro de Biotecnologia e Terapia Celular. They will be submitted to several tests, including: * Collection of Blood samples for biochemical analysis; * Electrocardiogram; * Holter Electrocardiogram; * Echocardiogram; * Treadmill Test; * X-Ray Imaging; * Magnetic Resonance Imaging; * Evaluation of the quality of life through the application of questionnaires (SF 36 and the Minnesota Living With Heart Failure Questionnaire).
Study Type
OBSERVATIONAL
Enrollment
60
Hospital São Rafael
Salvador, Estado de Bahia, Brazil
Correlation of plasmatic levels of MicroRNAs with the percentage of heart fibrosis
Mensuration of heart fibrosis percentage with Magnetic Resonance Imaging
Time frame: One year
Correlation of plasmatic levels of MicroRNAs with the functional cardiovascular capacity
Mensuration of the functional capacity with treadmill test.
Time frame: One year
Correlation of plasmatic levels of MicroRNAs with the left ventricular function
Mensuration of the left ventricular function with echocardiogram and magnetic resonance imaging
Time frame: One year
Correlation of plasmatic levels of MicroRNAs with the serum levels of Pro-BNP.
Time frame: One year
Correlation of plasmatic levels of MicroRNAs with the serum levels of TNF-alpha
Time frame: One year
Correlation of plasmatic levels of MicroRNAs with the serum levels of IFN-gamma.
Time frame: One year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.